David A. Siegel Iridex Corp Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$2.48 - $4.66 $6,200 - $11,650
-2,500 Reduced 14.2%
15,100 $39,000
Q1 2022

May 16, 2022
SELL
$3.99 - $6.42 $4,389 - $7,062
-1,100 Reduced 5.88%
17,600 $81,000
Q4 2021

Feb 14, 2022
BUY
$5.62 - $9.37 $105,094 - $175,218
18,700 New
18,700 $114,000

Others Institutions Holding IRIX

# of Institutions
31
Shares Held
3.3M
Call Options Held
500
Put Options Held
33.5K
View Full List

About IRIDEX CORP

IRIX Quotes by TradingView
  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $27.7M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email